GENERIX - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 180,022 | 199,884 | 181,044 | 203,991 | 168,170 | 166,091 | 155,168 | 183,463 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 1,505 | 3,505 | 8,184 | 5,000 | -12,913 | -5,581 | -11,818 | 6,609 |
| Equity | 508,598 | 512,101 | 520,284 | 526,248 | 513,335 | 507,754 | 485,936 | 480,782 |
| Liabilities | 24,292 | 4,296 | 19,416 | 5,754 | 6,861 | 16,516 | 13,874 | 23,612 |
| Non-current assets | 243,030 | 241,918 | 239,569 | 258,523 | 252,708 | 246,893 | 224,079 | 174,244 |
| Current assets | 289,860 | 274,270 | 299,972 | 273,010 | 266,896 | 276,936 | 275,290 | 328,812 |
| Total assets | 532,890 | 516,188 | 539,541 | 531,533 | 519,604 | 523,829 | 499,369 | 503,056 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 31,287 | 31,127 | 36,145 |
| Social insurance contributions | - | - | - | - | - | 12,085 | 10,443 | 9,826 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -24.4% | +11.0% | -9.4% | +12.7% | -17.6% | -1.2% | -6.6% | +18.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.3% | 0.7% | 1.5% | 0.9% | -2.5% | -1.1% | -2.4% | 1.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.3% | 0.7% | 1.6% | 1.0% | -2.5% | -1.1% | -2.4% | 1.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.8% | 1.8% | 4.5% | 2.5% | -7.7% | -3.4% | -7.6% | 3.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 37,246 | 49,971 | 46,224 | 46,186 | 33,634 | 33,218 | 36,510 | 45,866 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
GENERIX - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-05-16 | 2024-05-19 | 299.40 |
| 2022-09-16 | 2022-09-18 | 1.27 |
GENERIX - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-01-17 | 2025-01-23 | 0.78 |
| 2025-01-15 | 2025-01-16 | 1459.68 |
| 2025-01-10 | 2025-01-14 | 1454.22 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
GENERIX, UAB (code 122752661) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In financial year 2025, the company generated revenue of EUR 183.5K, increasing 18.2% year on year and 10.5% over two years. Net profit turned positive at EUR 6.6K after losses of EUR 5.6K in 2023 and EUR 11.8K in 2024, and the profit margin improved to 3.6%. The balance sheet remained stable and strongly equity financed: total assets were EUR 503.1K, equity EUR 480.8K and liabilities EUR 23.6K. This corresponds to an equity ratio of 95.6% and debt-to-equity of 0.05. Asset turnover stood at 0.36x, while ROE was 1.4% and ROA 1.3%. Long-term assets fell to EUR 174.2K, while short-term assets increased to EUR 328.8K. Revenue per employee reached EUR 45.9K and profit per employee EUR 1.7K, showing a return to profitability in 2025 after a weaker 2024.